Inclusion Criteria:  women participating in a cervical cancer screening program using an HPV assay as primary screening test positivity to hrHPV; written informed consent given.  Exclusion Criteria:  total hysterectomy; diagnosis of CIN2+ in the last two years; hrHPV negative or inadequate.